| scholarly article | Q13442814 |
| P50 | author | Elías Campo | Q5830202 |
| P2093 | author name string | Suarez M | |
| Gascon P | |||
| Corominas JM | |||
| Serrano S | |||
| Fernandez PL | |||
| Albanell J | |||
| Tusquets I | |||
| Rovira A | |||
| Ferrer B | |||
| Bellosillo B | |||
| Fabregat X | |||
| Montagut C | |||
| Campas C | |||
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 607-616 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients | |
| P478 | volume | 13 |
| Q36393078 | Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells |
| Q38952569 | Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response |
| Q37471658 | Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review |
| Q37097417 | Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies |
| Q35889130 | Chemosensitization in non-small cell lung cancer cells by IKK inhibitor occurs via NF-kappaB and mitochondrial cytochrome c cascade |
| Q34250350 | Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer |
| Q35604870 | Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer |
| Q38728499 | Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB. |
| Q37649660 | Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer |
| Q36217154 | Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells. |
| Q36261565 | Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance |
| Q34311701 | Immunogenic cell death and DAMPs in cancer therapy |
| Q37277130 | Immunohistochemical characterization of subtypes of male breast carcinoma |
| Q46036136 | NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. |
| Q91695617 | NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition |
| Q35469769 | NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms. |
| Q57306207 | NQO1 expression correlates inversely with NFκB activation in human breast cancer |
| Q36217015 | Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma. |
| Q34962518 | Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement |
| Q36650923 | Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line |
| Q35458969 | PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. |
| Q91904566 | Pentoxifylline Enhances the Apoptotic Effect of Carboplatin in Y79 Retinoblastoma Cells |
| Q49821547 | Quercetin Suppresses CYR61-Mediated Multidrug Resistance in Human Gastric Adenocarcinoma AGS Cells |
| Q44707208 | Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q37589832 | Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss. |
| Q37527497 | Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system |
| Q86542564 | Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer |
| Q36589909 | TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis |
| Q55302804 | The Direct and Indirect Roles of NF-κB in Cancer: Lessons from Oncogenic Fusion Proteins and Knock-in Mice. |
| Q92287734 | The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients |
| Q92761313 | The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence |
| Q39502331 | The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). |
| Q34845829 | The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer |
| Q90257740 | The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance |
| Q93360009 | The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers |
| Q47813995 | The nuclear factor-kappa B pathway and response to treatment in breast cancer |
| Q37193234 | The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment |
| Q38345954 | The role of oxidative stress in anticancer activity of sesquiterpene lactones |
| Q34428947 | Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling |
| Q55274989 | Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells. |
| Q94546979 | Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer |
Search more.